Dysferlinopathies refer to a spectrum of muscular dystrophies that cause progressive muscle
weakness and degeneration. They are caused by mutations in the DYSF gene, which …

There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD)
type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor …

Rhabdomyolysis has been reported in patients who abuse synthetic cannabinoids.
However, no studies have yet assessed whether these cases reflect the direct cytotoxicity of …

We report that, labeling mouse muscle tissue, with mouse monoclonal antibodies specific to
slow or fast myosin heavy chain (sMyHC and fMyHC, respectively), can lead to artefactual …

Introduction Dysferlin‐deficient murine muscle sustains severe damage after repeated
eccentric contractions. Methods With a robotic dynamometer, we studied the response of …

Progressive resistance training (PRT), which involves performing muscle contractions
against progressively greater external loads, can increase muscle mass and strength in …

Introduction The aim of this study was to quantify the extent of donor-cell-derived
myogenesis achieved by a novel surgical technique known as Minimally Invasive Muscle …

Investigator’s influence on the muscle strength assessment in animals in experiment:
Comparison of automated “inverted gri Page 1 63 ОРИГИНАЛЬНАЯ СТАТЬЯ Том 12 …

The previous wastebasket term “limb girdle muscular dystrophy” has been transformed into
a multitude of specific, genetically defined disorders. In 2017, the European Neuromuscular …

We report that, labeling mouse muscle tissue, with mouse monoclonal antibodies specific to
slow or fast myosin heavy chain (sMyHC and fMyHC, respectively), can lead to artefactual …